• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络的疾病中血管平滑肌细胞增殖调控因子的优先级排序和验证。

Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease.

机构信息

Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.

Functional Gene Control Group, MRC Laboratory of Medical Sciences, London, UK.

出版信息

Nat Cardiovasc Res. 2024 Jun;3(6):714-733. doi: 10.1038/s44161-024-00474-4. Epub 2024 Jun 6.

DOI:10.1038/s44161-024-00474-4
PMID:39215134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182749/
Abstract

Aberrant vascular smooth muscle cell (VSMC) homeostasis and proliferation characterize vascular diseases causing heart attack and stroke. Here we elucidate molecular determinants governing VSMC proliferation by reconstructing gene regulatory networks from single-cell transcriptomics and epigenetic profiling. We detect widespread activation of enhancers at disease-relevant loci in proliferation-predisposed VSMCs. We compared gene regulatory network rewiring between injury-responsive and nonresponsive VSMCs, which suggested shared transcription factors but differing target loci between VSMC states. Through in silico perturbation analysis, we identified and prioritized previously unrecognized regulators of proliferation, including RUNX1 and TIMP1. Moreover, we showed that the pioneer transcription factor RUNX1 increased VSMC responsiveness and that TIMP1 feeds back to promote VSMC proliferation through CD74-mediated STAT3 signaling. Both RUNX1 and the TIMP1-CD74 axis were expressed in human VSMCs, showing low levels in normal arteries and increased expression in disease, suggesting clinical relevance and potential as vascular disease targets.

摘要

血管平滑肌细胞(VSMC)的异常稳态和增殖是导致心脏病发作和中风等血管疾病的特征。在这里,我们通过重建单细胞转录组学和表观遗传谱分析的基因调控网络,阐明了调控 VSMC 增殖的分子决定因素。我们在增殖倾向的 VSMC 中检测到与疾病相关的基因座上广泛激活的增强子。我们比较了损伤反应性和非反应性 VSMC 之间的基因调控网络重排,这表明 VSMC 状态之间存在共享的转录因子,但靶基因座不同。通过计算机模拟干扰分析,我们确定并优先考虑了增殖的先前未被识别的调控因子,包括 RUNX1 和 TIMP1。此外,我们表明,先驱转录因子 RUNX1 增加了 VSMC 的反应性,而 TIMP1 通过 CD74 介导的 STAT3 信号反馈促进 VSMC 增殖。RUNX1 和 TIMP1-CD74 轴在人 VSMC 中表达,在正常动脉中表达水平较低,在疾病中表达水平升高,提示其具有临床相关性和作为血管疾病靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/f5efb9025be6/44161_2024_474_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/501a74c8c9c4/44161_2024_474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/3be9b5a43929/44161_2024_474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/199f2e94fccf/44161_2024_474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/4f26f7cef693/44161_2024_474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/e12b37d69741/44161_2024_474_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/021c115208cf/44161_2024_474_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/a6bd3821fcf8/44161_2024_474_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/2c485a8db46f/44161_2024_474_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/0fb872bbde51/44161_2024_474_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/5094766ee28c/44161_2024_474_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/a417cd003b32/44161_2024_474_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/1b32a0ab2037/44161_2024_474_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/f25be973252b/44161_2024_474_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/67da3f11334d/44161_2024_474_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/e1e86c7407f5/44161_2024_474_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/f5efb9025be6/44161_2024_474_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/501a74c8c9c4/44161_2024_474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/3be9b5a43929/44161_2024_474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/199f2e94fccf/44161_2024_474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/4f26f7cef693/44161_2024_474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/e12b37d69741/44161_2024_474_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/021c115208cf/44161_2024_474_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/a6bd3821fcf8/44161_2024_474_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/2c485a8db46f/44161_2024_474_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/0fb872bbde51/44161_2024_474_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/5094766ee28c/44161_2024_474_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/a417cd003b32/44161_2024_474_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/1b32a0ab2037/44161_2024_474_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/f25be973252b/44161_2024_474_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/67da3f11334d/44161_2024_474_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/e1e86c7407f5/44161_2024_474_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee69/11182749/f5efb9025be6/44161_2024_474_Fig16_ESM.jpg

相似文献

1
Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease.基于网络的疾病中血管平滑肌细胞增殖调控因子的优先级排序和验证。
Nat Cardiovasc Res. 2024 Jun;3(6):714-733. doi: 10.1038/s44161-024-00474-4. Epub 2024 Jun 6.
2
Silencing of mitigates the proliferation and migration of vascular smooth muscle cells and vascular intimal hyperplasia by suppressing STAT3/DRP1-mediated mitochondrial fission.通过抑制STAT3/DRP1介导的线粒体分裂,[基因名称]的沉默减轻了血管平滑肌细胞的增殖和迁移以及血管内膜增生。 (注:原文中Silencing of 后面缺少具体基因名称)
Acta Biochim Biophys Sin (Shanghai). 2024 Sep 11;57(4):633-645. doi: 10.3724/abbs.2024154.
3
Role of the signal transducer and activator of transcription 3 protein in the proliferation of vascular smooth muscle cells.信号转导和转录激活因子3蛋白在血管平滑肌细胞增殖中的作用。
Vascular. 2020 Dec;28(6):821-828. doi: 10.1177/1708538120929504. Epub 2020 Jun 2.
4
STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.信号转导和转录激活因子3(STAT3)蛋白通过与心肌转录辅激活因子相互作用调节血管平滑肌细胞表型转换。
J Biol Chem. 2015 Aug 7;290(32):19641-52. doi: 10.1074/jbc.M114.630111. Epub 2015 Jun 22.
5
Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.来源于烟雾病诱导多能干细胞的血管平滑肌细胞——与血管内皮细胞转录组的比较特征分析。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105305. doi: 10.1016/j.jstrokecerebrovasdis.2020.105305. Epub 2020 Sep 23.
6
BAG3 promotes proliferation and migration of arterial smooth muscle cells by regulating STAT3 phosphorylation in diabetic vascular remodeling.BAG3 通过调节糖尿病血管重构中 STAT3 的磷酸化促进动脉平滑肌细胞的增殖和迁移。
Cardiovasc Diabetol. 2024 Apr 25;23(1):140. doi: 10.1186/s12933-024-02216-z.
7
Pathological cyclic strain promotes proliferation of vascular smooth muscle cells via the ACTH/ERK/STAT3 pathway.病理性循环应变通过 ACTH/ERK/STAT3 通路促进血管平滑肌细胞增殖。
J Cell Biochem. 2018 Nov;119(10):8260-8270. doi: 10.1002/jcb.26839. Epub 2018 Jun 26.
8
Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease.心血管疾病中寡克隆血管平滑肌细胞扩张的细胞机制。
Cardiovasc Res. 2023 May 22;119(5):1279-1294. doi: 10.1093/cvr/cvac138.
9
miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.miR-22 是血管平滑肌细胞表型调节和新生内膜形成的一种新型介质。
Circulation. 2018 Apr 24;137(17):1824-1841. doi: 10.1161/CIRCULATIONAHA.117.027799. Epub 2017 Dec 15.
10
[Stat 3 signal transduction pathway correlates with proliferation of vascular smooth muscle cells of rats].[信号转导与转录激活因子3信号转导通路与大鼠血管平滑肌细胞增殖的相关性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Sep;33(9):832-5.

引用本文的文献

1
Delineation of a thrombin receptor-stimulated vascular smooth muscle cell transition generating cells in the plaque-stabilising fibrous cap.确定凝血酶受体刺激的血管平滑肌细胞转变产生斑块稳定纤维帽中的细胞。
Cardiovasc Res. 2025 Jun 27. doi: 10.1093/cvr/cvaf112.
2
Single-cell transcriptomics reveals cellular dynamics and chemokine CXCL2-mediated smooth muscle cell proliferation in arterial repair.单细胞转录组学揭示了动脉修复过程中的细胞动态变化以及趋化因子CXCL2介导的平滑肌细胞增殖。
Front Immunol. 2025 May 20;16:1591557. doi: 10.3389/fimmu.2025.1591557. eCollection 2025.
3
Metabolic and Immune Crosstalk in Cardiovascular Disease.

本文引用的文献

1
Clonal Expansion in Cardiovascular Pathology.心血管病理学中的克隆性扩增
JACC Basic Transl Sci. 2023 Jul 19;9(1):120-144. doi: 10.1016/j.jacbts.2023.04.008. eCollection 2024 Jan.
2
Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation.组织金属蛋白酶抑制剂-1 与 CD74 相互作用促进 AKT 信号转导、单核细胞募集反应和血管平滑肌细胞增殖。
Cells. 2023 Jul 20;12(14):1899. doi: 10.3390/cells12141899.
3
Dissecting cell identity via network inference and in silico gene perturbation.
心血管疾病中的代谢与免疫相互作用
Circ Res. 2025 May 23;136(11):1433-1453. doi: 10.1161/CIRCRESAHA.125.325496. Epub 2025 May 22.
4
Coronary Artery Spasm: From Physiopathology to Diagnosis.冠状动脉痉挛:从病理生理学到诊断
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
通过网络推断和计算机基因扰动解析细胞身份。
Nature. 2023 Feb;614(7949):742-751. doi: 10.1038/s41586-022-05688-9. Epub 2023 Feb 8.
4
Genetic Regulation of SMC Gene Expression and Splicing Predict Causal CAD Genes.SMC 基因表达和剪接的遗传调控预测 CAD 的因果基因。
Circ Res. 2023 Feb 3;132(3):323-338. doi: 10.1161/CIRCRESAHA.122.321586. Epub 2023 Jan 4.
5
Translational opportunities of single-cell biology in atherosclerosis.单细胞生物学在动脉粥样硬化中的转化机会。
Eur Heart J. 2023 Apr 7;44(14):1216-1230. doi: 10.1093/eurheartj/ehac686.
6
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.在超过 100 万名参与者中发现并系统地描述了冠心病的风险变异和基因。
Nat Genet. 2022 Dec;54(12):1803-1815. doi: 10.1038/s41588-022-01233-6. Epub 2022 Dec 6.
7
Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1β/STAT3 signaling.巨噬细胞通过 IL-1β/STAT3 信号通路调节动脉粥样硬化进程中的血管平滑肌细胞功能。
Commun Biol. 2022 Dec 1;5(1):1316. doi: 10.1038/s42003-022-04255-2.
8
Cut loose TIMP-1: an emerging cytokine in inflammation.释放基质金属蛋白酶组织抑制因子-1:一种在炎症中崭露头角的细胞因子。
Trends Cell Biol. 2023 May;33(5):413-426. doi: 10.1016/j.tcb.2022.08.005. Epub 2022 Sep 23.
9
Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease.心血管疾病中寡克隆血管平滑肌细胞扩张的细胞机制。
Cardiovasc Res. 2023 May 22;119(5):1279-1294. doi: 10.1093/cvr/cvac138.
10
Dichotomous Roles of Smooth Muscle Cell-Derived MCP1 (Monocyte Chemoattractant Protein 1) in Development of Atherosclerosis.平滑肌细胞源性单核细胞趋化蛋白 1(MCP1)在动脉粥样硬化发展中的双重作用。
Arterioscler Thromb Vasc Biol. 2022 Aug;42(8):942-956. doi: 10.1161/ATVBAHA.122.317882. Epub 2022 Jun 23.